New strategies to empower patients with chronic kidney disease in phosphorus control (empower-PHOS)

Read full text Summarise with VIRAT
Authors: María Dolores Arenas Jiménez, María Delgado García de Polavieja, Soraya Escribano, Julia Audije-Gil, Ma Luz Sánchez Tocino, Fernando Henríquez, Gloria Antón Pérez, Delfina Yetman, Mónica Pereira, Pablo Molina, María Auxiliadora Bajo, María Jesús Lloret
+13 more Aina Quilis, Carlos Fernández Fernández, Camino García Monteavaro, Lina María León, Ana Botella, Judith Ballart, Alba Durbá, Karina Furaz, Emilio González Parra, Marc Handel, María Delgado Yagüe, José Antonio Herrero, Fabiola Dapena
Cited by: 0
References: 19

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

INTRODUCTION: Serum phosphorus (P) control in hemodialysis (HD) remains a major challenge, largely influenced by phosphate binder adherence and patient engagement. Structured educational strategies may enhance self-care and improve clinical outcomes. OBJECTIVE: To evaluate the effectiveness of a patient-centered educational intervention for phosphorus control in hemodialysis. MATERIAL AND METHODS: Multicenter, prospective, randomized clinical trial including patients with hyperphosphatemia or high binder requirements, allocated to an intervention group (structured education + Empower-PHOS tool) or a control group (standard care). Serum P, binder dose, and adherence (SMAQ) were assessed at baseline and at 3, 6, and 12 months. RESULTS: Both groups were comparable at baseline. A total of 122 patients from 14 centers were enrolled. The intervention group achieved significant reductions in serum P at 3 months (from 6.1 to 5.4 mg/dl; p < .001) and at 12 months (from 6.2 to 5.2 mg/dl; p = .010), without changes in the number of pills or daily binder dose. Improvements were observed in both adherent and non-adherent patients, with particularly notable reductions among the latter (from 6.4 ± 1.2 to 5.8 ± 1.2 mg/dl; p = .015). Adherence according to SMAQ did not change significantly. CONCLUSIONS: A structured, patient-centered educational intervention improved phosphorus control in hemodialysis, even among patients with low baseline adherence, without increasing the pharmacological burden. These findings support the integration of personalized educational strategies as a key component in the comprehensive management of hyperphosphatemia in routine hemodialysis practice.

Fields of Study & Subjects

Parathyroid Disorders and Treatments Dialysis and Renal Disease Management Medication Adherence and Compliance

Publication details

Journal / source
Nefrología (English Edition)
Volume
46
Issue
4
Pages
501488–501488
Publication date
30 March 2026
Language
EN